240 related articles for article (PubMed ID: 22304817)
21. In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters.
Durmus S; Naik J; Buil L; Wagenaar E; van Tellingen O; Schinkel AH
Int J Cancer; 2014 Oct; 135(7):1700-10. PubMed ID: 24554572
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
23. Effects of anthocyans on the expression of organic anion transporting polypeptides (SLCOs/OATPs) in primary human hepatocytes.
Riha J; Brenner S; Srovnalova A; Klameth L; Dvorak Z; Jäger W; Thalhammer T
Food Funct; 2015 Mar; 6(3):772-9. PubMed ID: 25578040
[TBL] [Abstract][Full Text] [Related]
24. Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice.
van de Steeg E; van Esch A; Wagenaar E; Kenworthy KE; Schinkel AH
Clin Cancer Res; 2013 Feb; 19(4):821-32. PubMed ID: 23243220
[TBL] [Abstract][Full Text] [Related]
25. Interactions of crizotinib and gefitinib with organic anion-transporting polypeptides (OATP)1B1, OATP1B3 and OATP2B1: gefitinib shows contradictory interaction with OATP1B3.
Sato T; Ito H; Hirata A; Abe T; Mano N; Yamaguchi H
Xenobiotica; 2018 Jan; 48(1):73-78. PubMed ID: 28005438
[TBL] [Abstract][Full Text] [Related]
26. Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein.
Higgins JW; Bao JQ; Ke AB; Manro JR; Fallon JK; Smith PC; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2014 Jan; 42(1):182-92. PubMed ID: 24194513
[TBL] [Abstract][Full Text] [Related]
27. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
28. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green.
de Graaf W; Häusler S; Heger M; van Ginhoven TM; van Cappellen G; Bennink RJ; Kullak-Ublick GA; Hesselmann R; van Gulik TM; Stieger B
J Hepatol; 2011 Apr; 54(4):738-45. PubMed ID: 21163547
[TBL] [Abstract][Full Text] [Related]
29. Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.
Takanohashi T; Kubo S; Arisaka H; Shinkai K; Ubukata K
J Pharm Pharmacol; 2012 Feb; 64(2):199-206. PubMed ID: 22221095
[TBL] [Abstract][Full Text] [Related]
30. Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.
De Bruyn T; Fattah S; Stieger B; Augustijns P; Annaert P
J Pharm Sci; 2011 Nov; 100(11):5018-30. PubMed ID: 21837650
[TBL] [Abstract][Full Text] [Related]
31. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.
Niemi M; Pasanen MK; Neuvonen PJ
Pharmacol Rev; 2011 Mar; 63(1):157-81. PubMed ID: 21245207
[TBL] [Abstract][Full Text] [Related]
32. The effect of organic anion-transporting polypeptides 1B1, 1B3 and 2B1 on the antitumor activity of flavopiridol in breast cancer cells.
Brenner S; Riha J; Giessrigl B; Thalhammer T; Grusch M; Krupitza G; Stieger B; Jäger W
Int J Oncol; 2015 Jan; 46(1):324-32. PubMed ID: 25351763
[TBL] [Abstract][Full Text] [Related]
33. Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas.
Kim M; Deacon P; Tirona RG; Kim RB; Pin CL; Meyer Zu Schwabedissen HE; Wang R; Schwarz UI
Histochem Cell Biol; 2017 Oct; 148(4):345-357. PubMed ID: 28493059
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells.
Riha J; Brenner S; Böhmdorfer M; Giessrigl B; Pignitter M; Schueller K; Thalhammer T; Stieger B; Somoza V; Szekeres T; Jäger W
Mol Nutr Food Res; 2014 Sep; 58(9):1830-42. PubMed ID: 24996158
[TBL] [Abstract][Full Text] [Related]
35. The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.
Miyagawa M; Maeda K; Aoyama A; Sugiyama Y
J Pharmacol Exp Ther; 2009 May; 329(2):551-7. PubMed ID: 19244099
[TBL] [Abstract][Full Text] [Related]
36. Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3.
Martinez-Becerra P; Briz O; Romero MR; Macias RI; Perez MJ; Sancho-Mateo C; Lostao MP; Fernandez-Abalos JM; Marin JJ
Mol Pharmacol; 2011 Mar; 79(3):596-607. PubMed ID: 21173039
[TBL] [Abstract][Full Text] [Related]
37. Steroid hormones specifically modify the activity of organic anion transporting polypeptides.
Koenen A; Köck K; Keiser M; Siegmund W; Kroemer HK; Grube M
Eur J Pharm Sci; 2012 Nov; 47(4):774-80. PubMed ID: 22982504
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of hepatic uptake transporters by flavonoids.
Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
[TBL] [Abstract][Full Text] [Related]
39. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
Alam K; Farasyn T; Crowe A; Ding K; Yue W
PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
[TBL] [Abstract][Full Text] [Related]
40. Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes.
Kimoto E; Yoshida K; Balogh LM; Bi YA; Maeda K; El-Kattan A; Sugiyama Y; Lai Y
Mol Pharm; 2012 Dec; 9(12):3535-42. PubMed ID: 23082789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]